117 related articles for article (PubMed ID: 8986147)
1. Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia.
Volm M; Zintl F; Edler L; Sauerbrey A
Med Pediatr Oncol; 1997 Feb; 28(2):117-26. PubMed ID: 8986147
[TBL] [Abstract][Full Text] [Related]
2. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of resistance proteins in initial acute lymphatic leukemia (ALL) in childhood].
Sauerbrey A; Volm M; Zintl F
Klin Padiatr; 1995; 207(4):230-4. PubMed ID: 7564159
[TBL] [Abstract][Full Text] [Related]
4. Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia.
Stammler G; Sauerbrey A; Volm M
Cancer Lett; 1995 Feb; 89(1):129-35. PubMed ID: 7882295
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia.
Sauerbrey A; Zintl F; Volm M
Br J Cancer; 1994 Dec; 70(6):1144-9. PubMed ID: 7981066
[TBL] [Abstract][Full Text] [Related]
6. Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome.
Goasguen JE; Lamy T; Bergeron C; Ly Sunaram B; Mordelet E; Gorre G; Dossot JM; Le Gall E; Grosbois B; Le Prisé PY; Fauchet R
Leuk Lymphoma; 1996 Nov; 23(5-6):567-76. PubMed ID: 9031088
[TBL] [Abstract][Full Text] [Related]
7. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.
Yokoyama Y; Sagara M; Sato S; Saito Y
Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
[TBL] [Abstract][Full Text] [Related]
8. Correlated expression of glutathione S-transferase-pi and c-Jun or other oncogene products in human squamous cell carcinomas of the head and neck: relevance to relapse after radiation therapy.
Miura K; Suzuki S; Tanita J; Shinkawa H; Satoh K; Tsuchida S
Jpn J Cancer Res; 1997 Feb; 88(2):143-51. PubMed ID: 9119742
[TBL] [Abstract][Full Text] [Related]
9. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase and P-glycoprotein expressions in neuroblastoma.
Kutlik MT; Ayhan A; Göğüş S; Yalçin B; Cağlar M; Büyükpamukçu M
Pediatr Hematol Oncol; 2002; 19(5):337-45. PubMed ID: 12078865
[TBL] [Abstract][Full Text] [Related]
11. Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL).
Sauerbrey A; Zintl F; Hermann J; Volm M
Anticancer Res; 1998; 18(2B):1231-6. PubMed ID: 9615793
[TBL] [Abstract][Full Text] [Related]
12. Protein expression profile of newly diagnosed acute lymphoblastic leukemia in children developing relapses.
Volm M; Sauerbrey A; Zintl F; Koomägi R; Efferth T
Oncol Rep; 2002; 9(5):965-9. PubMed ID: 12168056
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.
Volm M; Drings P; Wodrich W
J Cancer Res Clin Oncol; 1993; 119(9):507-10. PubMed ID: 8100821
[TBL] [Abstract][Full Text] [Related]
14. Detection of resistance proteins in matched primary lung tumors and lymph node metastases.
Mattern J; Volm M
Anticancer Res; 1994; 14(2A):417-9. PubMed ID: 7912493
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
Utz I; Gekeler V; Ise W; Beck J; Spitaler M; Grunicke H; Hofmann J
Anticancer Res; 1996; 16(1):289-96. PubMed ID: 8615623
[TBL] [Abstract][Full Text] [Related]
16. Dihydrofolate-reductase and thymidylate-synthase in childhood acute lymphoblastic leukemia.
Volm M; Sauerbrey A; Zintl F
Anticancer Res; 1994; 14(3B):1377-81. PubMed ID: 8067709
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study.
Dhooge C; De Moerloose B; Laureys G; Kint J; Ferster A; De Bacquer D; Philippe J; Benoit Y
Br J Haematol; 1999 Jun; 105(3):676-83. PubMed ID: 10354131
[TBL] [Abstract][Full Text] [Related]
18. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
19. Prediction of drug resistance in human tumors using immunohistochemical techniques.
Mattern J; Volm M
Anticancer Res; 1992; 12(2):413-8. PubMed ID: 1349793
[TBL] [Abstract][Full Text] [Related]
20. Associated expression of protein kinase C with resistance to doxorubicin in human lung cancer.
Volm M; Pommerenke EW
Anticancer Res; 1995; 15(2):463-6. PubMed ID: 7763022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
